LeMaitre Q4 2025 sales $64.5M (+16%), EPS $0.68 (+39%), raises dividend 25%

LEMAITRE VASCULAR INC

2025-FY EPS reported $2.52 revenue$249,602,000

Q4 2025 sales $64.5M (+16% YoY, +15% organic); diluted EPS $0.68 (+39%).
Gross margin 71.7% (+240 bps); operating income $18.8M (+47%).
Quarterly dividend increased 25% to $0.25/share; payable March 26, 2026 to holders of record March 12, 2026.
Board authorized $100M share repurchase program, expiring February 18, 2027.
FY2026 guidance: sales mid $280M (+12%), adj. op. income +21%, adj. EPS +22%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.